Uveitis is an inflammatory condition of the eye that can cause vision loss and other complications. Immune disorders drugs are used to treat uveitis and other immune-mediated diseases. These drugs are designed to reduce inflammation and suppress the immune system. Commonly used drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and reduce inflammation.
The uveitis drug market is a rapidly growing segment of the immune disorders drugs market. It is driven by the increasing prevalence of uveitis and other immune-mediated diseases, as well as the development of new drugs and treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more